LeonaBio, Inc. Share Price

LeonaBio, Inc. Share Price

NASDAQ: LONA | Micro Cap
$4.90
-$0.10 (-2%) Last updated on 30 Oct, 2026 | 01:23 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

LeonaBio, Inc. Stock Performance

Open
$5.12
Prev. Close
$5.00
Circuit Range
N/A
Day Range
$5.12 - $5.13
Year Range
$2.24 - $14.05
Volume
581
Average Traded
$5.13

LeonaBio, Inc. Share Price Today

As of 31 October 2026, LeonaBio, Inc.'s share price is $4.90. The stock opened at $5.12, compared to its previous close of $5.00. During today's trading session, LeonaBio, Inc.'s share price traded between $5.12 and $5.13, with an average price of $5.13. Over the past 52 weeks, the stock has recorded a high of $14.05 and a low of $2.24. In terms of performance, LeonaBio, Inc.'s share price has declined by 43.25% over the last six months and is up 2.30% on a year-on-year basis.

LeonaBio, Inc. Share Price Chart

Line chart of the LeonaBio, Inc. price trend over the selected period. The price fell overall, ranging from 4.74 to 5.03, ending at 4.74.
$5.12$5.13
L
Show Current Price
H

LeonaBio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$20.95M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-15.01
Revenue (TTM)
N/A
Return On Equity (TTM)
-421.09%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
N/A

LeonaBio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2026Jun 2026
Revenue$0.00$0.00
Net Profit-$32.96-$19.01
Net Profit MarginN/AN/A
Income ChangeN/A42.32%

About LeonaBio, Inc.

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

LeonaBio, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$3.52
$5.13
+53.74%
Sep 2026
$7.62
$3.34
-60.47%
Aug 2026
$7.29
$8.45
+15.12%
Jul 2026
$9.19
$7.34
-19.07%
Jun 2026
$8.83
$9.07
-6.30%
May 2026
$8.49
$9.68
+12.10%
Apr 2026
$10.41
$8.63
-15.47%
Mar 2026
$5.69
$10.21
+80.00%
Feb 2026
$4.65
$5.67
+18.48%
Jan 2026
$6.63
$4.79
N/A

LONA Share Price FAQs